Salomon & Ludwin
AMPH icon

Salomon & Ludwin’s Amphastar Pharmaceuticals AMPH Stock Holding History

Salomon & Ludwin’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.8K Buy
458
+377
+465% +$8.15K ﹤0.01% 1254
2026
Q2 		$1.63K Buy
+81
New +$1.63K ﹤0.01% 1981
2026
Q1 		– Sell
-229
Closed -$6.12K – 2101
2025
Q4 		$6.12K Sell
229
-148
-39% -$3.81K ﹤0.01% 1707
2025
Q3 		$10.1K Buy
+377
New +$9.7K ﹤0.01% 1299

Other funds holding AMPH

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
LAM Group
LAM Group Lake Oswego, Oregon $199M AUM 14.21% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

Salomon & Ludwin's AMPH Position: Q3 2026 in Review

Salomon & Ludwin increased its Amphastar Pharmaceuticals (AMPH) stake by 465% in Q3 2026, buying an estimated $8.15K and bringing the position to 458 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Salomon & Ludwin first reported a position in AMPH in Q3 2025 and has held it in 4 quarters since. 79 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Salomon & Ludwin held 458 shares of Amphastar Pharmaceuticals worth $11.8K as of Q3 2026.
  • Salomon & Ludwin bought 377 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $8.15K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1254 holding.
  • Salomon & Ludwin first reported a position in Amphastar Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 79 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.